Nivan Pharmaceuticals India Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 25-05-2024
- Paid Up Capital ₹ 0.10 M
as on 25-05-2024
- Company Age 16 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
About Nivan Pharmaceuticals India
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Maya Kudchadkar and Rohan Kudchadkar serve as directors at the Company.
- CIN/LLPIN
U24234GA2008PTC005849
- Company No.
005849
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Aug 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Goa
Industry
Company Details
- Location
South Goa, Goa, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Nivan Pharmaceuticals India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Maya Kudchadkar  | Director | 29-Sep-2012 | Current |
| Rohan Kudchadkar | Director | 01-Aug-2008 | Current |
Financial Performance of Nivan Pharmaceuticals India.
Nivan Pharmaceuticals India Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Nivan Pharmaceuticals India?
In 2017, Nivan Pharmaceuticals India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Immersoft Technologies Private LimitedActive 21 years 3 monthsMaya Kudchadkar and Rohan Kudchadkar are mutual person
- Navelim Finance And Investment Private LimitedActive 37 years 4 months
Maya Kudchadkar and Rohan Kudchadkar are mutual person
- Kushawati Land Developers Private LimitedActive 16 years 5 months
Maya Kudchadkar and Rohan Kudchadkar are mutual person
- Goa Shares & Stocks Investments Private LimitedActive 16 years 4 months
Maya Kudchadkar and Rohan Kudchadkar are mutual person
- Grace Shares & Stocks Trading Private LimitedActive 16 years 6 months
Maya Kudchadkar and Rohan Kudchadkar are mutual person
- Zuari Shares Broking Private LimitedActive 16 years 4 months
Maya Kudchadkar and Rohan Kudchadkar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nivan Pharmaceuticals India?
Unlock and access historical data on people associated with Nivan Pharmaceuticals India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nivan Pharmaceuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nivan Pharmaceuticals India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
